Lambert-Eaton Myasthenic Syndrome (LEMS): Shaping Patient Journeys Through Eye Care (In-Person CE Symposium)

October 19, 2024

To register for the symposium, please click Register/Take Course.

Saturday, October 19, 2024
6:00 PM – 6:30 PM CT Registration and Dinner
6:30 PM – 7:30 PM CT CE Symposium

Chicago Marriott Downtown Magnificent Mile

Salon 1, 7th Floor
540 North Michigan Avenue
Chicago, Illinois

Target Audience

This educational activity is intended for optometrists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Implement referrals on the basis of clinical features of Lambert-Eaton myasthenic syndrome
  • Identify the appropriate diagnostic measures for Lambert-Eaton myasthenic syndrome
  • Evaluate clinical trial data on treatment for Lambert-Eaton myasthenic syndrome
Course summary
Available credit: 
  • 1.00 COPE
Course opens: 
09/20/2024
Course expires: 
12/19/2024
Event starts: 
10/19/2024 - 7:30pm EDT
Event ends: 
10/19/2024 - 8:30pm EDT
Add to calendar: 

Faculty

Fiona Costello, MD, FRCPC (Co-Chair)
Professor of Neurology
Departments of Clinical Neurosciences and Surgery
Cumming School of Medicine
University of Calgary
Clinician Scientist
Hotchkiss Brain Institute
Calgary, Canada
Michael Lee, MD (Co-Chair)
Professor
Departments of Ophthalmology, Neurology, and Neurosurgery
Mackall-Scheie Endowed Chair
Director of Neuro-Ophthalmology
University of Minnesota
Minneapolis, Minnesota
  

Disclosure Policy

MedEdicus requires that anyone who is in a position to control the content of this educational activity disclose all relevant financial relationships with any commercial interest. Financial relationship information is collected and resolved prior to the educational activity.

Faculty

Fiona Costello, MD, is an advisory board member of Amgen Inc*; and is on the speakers bureau for Sanofi*.

Michael Lee, MD, is a consultant for Panbela Therapeutics, Inc; is an advisory board member of Amgen Inc*, is a contracted researcher for Invex Therapeutics*, and has stocks or stock options in Viridian Therapeutics, Inc*.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners, Managers, and Writers

MedEdicus planners and managers have no relevant commercial relationships to disclose.

* The financial relationship existed during the past 24 months but has now ended

Accreditation Statement

COPE approved for 1.0 CE credit for optometrists.
COPE Course ID: 93725-NO (Synchronous In Person)
COPE Course Category: Neuro-Optometry

Administrator: 

This activity, COPE Activity Number 129302, is accredited by COPE for continuing education for optometrists.

COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

Disclosure of Commercial Support

MedEdicus LLC has received commercial support from Catalyst Pharmaceuticals, Inc, for this activity in the form of an unrestricted educational grant.

The content of this COPE-accredited CE activity was planned and prepared independently by MedEdicus LLC without input from members of an ineligible company.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of  MedEdicus LLC or Catalyst Pharmaceuticals, Inc.

This CE activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 330.1

Available Credit

  • 1.00 COPE
Please login or register to take this course.

At the end of the symposium, please log into your account and select Take Course to complete the evaluation. A certificate will be made available immediately.

Note About Obtaining Credit: You must attend the course in its entirety. COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 24 hours of the program's completion.